Jim McDermott: “The use of Jackson-Vanik obviously had a point at some time in the past. Probably for the last 10 years it has been…”

In my opinion, it could be one of the most important hearings we have held during my time as ranking member on the subcommittee.

This committee has the potential of doing more good for the American people than perhaps any other single subcommittee in the Congress.

The bottom line, as far as I am concerned, is what happens to patients.

It has been a pleasure serving on this committee.